Are neurologic examination abnormalities heritable? A preliminary study

Schizophrenia Research

Volumn 86, Issue 1-3, 2006, Pages 172-180

  Sanders, R D ^a,b   Joo, Y H ^c   Almasy, L ^d   Wood, J ^c   Keshavan, M S ^e   Pogue Geile, M F ^c   Gur, R C ^f   Gur, R E ^f   Nimgaonkar, V L ^c  

^a Dayton VA   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Endophenotype; Genetic; Neurological soft signs; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COGNITION; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; ERROR; FEMALE; HERITABILITY; HUMAN; MALE; MEMORY; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PERCEPTION; PRIORITY JOURNAL; RATING SCALE; RELATIVE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; STATISTICS; STATISTICS AS TOPIC;

EID: 33747200451     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.06.012     Document Type: Article

References (61)

1. Almasy L., and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62 5 (1998) 1198-1211
2. Arango C., Bartko J.J., Gold J.M., and Buchanan R.W. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am. J. Psychiatry 156 9 (1999) 1349-1357
3. Bachmann S., Bottmer C., and Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am. J. Psychiatry 162 12 (2005) 2337-2343
4. Bhatia T., Franzos M.A., Wood J.A., Nimgaonkar V.L., and Deshpande S.Nrn. Gender and procreation among patients with schizophrenia. Schizophr. Res. 68 2-3 (2004) 387-394
5. Boks M.P., Liddle P.F., Burgerhof J.G., Knegtering R., and van den Bosch R.J. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr. Scand. 110 1 (2004) 29-35
6. Bombin I., Arango C., and Buchanan R.W. Assessment tools for soft signs. Psychiatr. Ann. 33 3 (2003) 170-180
7. Buchanan R.W., and Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 27 3 (1989) 335-350
8. Buchanan R.W., Strauss M.E., Kirkpatrick B., Holstein C., Breier A., and Carpenter Jr. W.T. Neuropsychological impairments in deficit vs. nondeficit forms of schizophrenia. Arch. Gen. Psychiatry 51 10 (1994) 804-811
9. Caligiuri M.P., Lohr J.B., and Jeste D.V. Parkinsonism in neuroleptic-naive schizophrenic patients. Am. J. Psychiatry 150 9 (1993) 1343-1348
10. Caligiuri M.P., Lohr J.B., Dean C., Sponheim S., and Hegeman B. Motor abnormalities in family members of patients with schizophrenia (abstract). Schizophr. Bull. 31 (2005) 265-266
11. Candela S.F., and Manschreck T.C. Neurologic soft signs in schizophrenia: research findings and clinical relevance. Psychiatr. Ann. 33 3 (2003) 157-166
12. Chen E.Y., Shapleske J., Luque R., McKenna P.J., Hodges J.R., Calloway S.P., Hymas N.F., Dening T.R., and Berrios G.Ern. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 56 2 (1995) 183-204
13. Chen E.Y., Kwok C.L., Au J.W., Chen R.Y., and Lau B.Srn. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr. Scand. 102 5 (2000) 342-349
14. Chen Y.L., Chen Y.H., and Mak F.L. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J. of Nerv. Ment. Dis. 188 2 (2000) 84-89
15. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., Deshpande S.N., B.K. T., Ferrell R.E., Middleton F.A., Devlin B., Levitt P., Lewis D.A., and Nimgaonkar V.L. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11 12 (2002) 1373-1380
16. Dazzan P., and Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. Br. J. Psychiatr., Suppl. 43 (2002) s50-s57
17. Duggirala R., Williams J.T., Williams-Blangero S., and Blangero J. A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet. Epidemiol. 14 6 (1997) 987-992
18. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Rawlings R., Hyde T.M., Bigelow L., and Weinberger D.Rrn. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol. Psychiatry 50 2 (2001) 98-107
19. Egan M.F., Hyde T.M., Bonomo J.B., Mattay V.S., Bigelow L.B., Goldberg T.E., and Weinberger D.R. Relative risk of neurological signs in siblings of patients with schizophrenia. Am. J. Psychiatry 158 11 (2001) 1827-1834
20. Flashman L.A., Flaum M., Gupta S., and Andreasen N.Crn. Soft signs and neuropsychological performance in schizophrenia. Am. J. Psychiatry 153 4 (1996) 526-532
21. Golden C.J., Purisch A., and Hammeke T. Luria-Nebraska Neuropsychological Battery Manual - Forms I and II (1985), Western Psychological Services, Los Angeles
22. Goldstein G., Sanders R.D., Forman S.D., Tarpey T., Gurklis J.A., Van Kammen D.P., and Keshavan M.S. The effects of antipsychotic medication on factor and cluster structure of neurologic examination abnormalities in schizophrenia. Schizophr. Res. 75 1 (2005) 55-64
23. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160 4 (2003) 636-645
24. Gourion D., Goldberger C., Olie J.P., Loo H., and Krebs M.Orn. Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophr. Res. 67 1 (2004) 23-31
25. Griffiths T.D., Sigmundsson T., Takei N., Rowe D., and Murray R.M. Neurological abnormalities in familial and sporadic schizophrenia. Brain 121 Pt 2 (1998) 191-203
26. Gupta S., Andreasen N.C., Arndt S., Flaum M., Schultz S.K., Hubbard W.C., and Smith M. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am. J. Psychiatry 152 2 (1995) 191-196
27. Gur R.C., Ragland J.D., Moberg P.J., Bilker W.B., Kohler C., Siegel S.J., and Gur R.E. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology 25 (2001) 777-788
28. Gur R.C., Ragland J.D., Moberg P.J., Turner T.H., Bilker W.B., Kohler C., Siegel S.J., and Gur R.E. Computerized neurocognitive scanning: I. Methodology and validation in healthy people. Neuropsychopharmacology 25 5 (2001) 766-776
29. Heinrichs D.W., and Buchanan R.W. Significance and meaning of neurological signs in schizophrenia. Am. J. Psychiatry 145 1 (1988) 11-18
30. Heinrichs R.W. In Search of Madness: Schizophrenia and Neuroscience (2001), Oxford University Press, Oxford
31. Horton A.M.J. Some suggestions regarding the clinical interpretation of the Trail Making Test. Clin. Neuropsychol. 1 1 (1979) 20-23
32. Ismail B., Cantor-Graae E., and McNeil T.F. Neurological abnormalities in schizophrenic patients and their siblings. Am. J. Psychiatry 155 1 (1998) 84-89
33. Jampala V.C., Gaither M.L., and Sanders R.D. Test-retest stability of the neurologic examination in stable schizophrenia (abstract). Schizophr. Res. 60 (2003) 18-19 (S)
34. Keshavan M.S., Sanders R.D., Sweeney J.A., Diwadkar V.A., Goldstein G., Pettegrew J.W., and Schooler N.R. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am. J. Psychiatry 160 7 (2003) 1298-1304
35. Lawrie S.M., Byrne M., Miller P., Hodges A., Clafferty R.A., Cunningham Owens D.G., and Johnstone E.C. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br. J. Psychiatry 178 (2001) 524-530
36. Madsen A.L., Vorstrup S., Rubin P., Larsen J.K., and Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr. Scand. 100 2 (1999) 119-125
37. Maxwell M., 1992. Family Interview for Genetic Studies (FIGS) : a manual for FIGS. Bethesda, Maryland, Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health.
38. McGee S. Evidence-Based Physical Diagnosis (2001), Saunders, Philadelphia
39. Merriam A.E., Kay S.R., Opler L.A., Kushner S.F., and van Praag H.Mrn. Neurological signs and the positive-negative dimension in schizophrenia. Biol. Psychiatry 28 3 (1990) 181-192
40. Mohr F., Hubmann W., Cohen R., Bender W., Haslacher C., Honicke S., Schlenker R., Wahlheim C., and Werther Prn. Neurological soft signs in schizophrenia: assessment and correlates. Eur. Arch. Psychiatry Clin. Neurosci. 246 5 (1996) 240-248
41. Niethammer R., Weisbrod M., Schiesser S., Grothe J., Maier S., Peter U., Kaufmann C., Schroder J., and Sauer H. Genetic influence on laterality in schizophrenia? A twin study of neurological soft signs. Am. J. Psychiatry 157 2 (2000) 272-274
42. Nurnberger Jr. J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., and Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 51 11 (1994) 849-859 (discussion 863-4)
43. Picchioni M.M., Toulopoulou T., Landau S., Davies N., Ribchester T., and Murray R.M. Neurological abnormalities in schizophrenic twins. Biol. Psychiatry 59 4 (2006) 341-348
44. Pogue-Geile M.F., Gur R.E., R.C. G., Almasy L., Wood J., Thompson J., Tarbox S., and Nimgaonkar V.L. Genetic liability to schizophrenia and executive functioning: initial results from a large-pedigree, multiplex sample (abstract). Schizophr. Bull. 31 (2005) 275
45. Potvin A.R., and Tourtellote W.W. Quantitative examination of neurologic functions (1985), CRC Press, Boca Raton, Fla
46. Rossi A., De Cataldo S., Di Michele V., Manna V., Ceccoli S., Stratta P., and Casacchia Mrn. Neurological soft signs in schizophrenia. Br. J. Psychiatry 157 (1990) 735-739
47. Sanders R.D., Forman S.D., Pierri J.N., Baker R.W., Kelley M.E., Van Kammen D.P., and Keshavan M.S. Inter-rater reliability of the neurological examination in schizophrenia. Schizophr. Res. 29 3 (1998) 287-292
48. Sanders R.D., McLaughlin N., Pierri J.N., Sweeney J.A., Haas G.L., and Keshavan M.S. Prognostic significance of neurologic examination abnormalities in neuroleptic-naive schizophrenia (abstract). J. Neuropsychiatry Clin. Neurosci. 12 (2000) 162
49. Sanders R.D., Keshavan M.S., Forman S.D., Pieri J.N., McLaughlin N., Allen D.N., van Kammen D.P., and Goldstein G. Factor structure of neurologic examination abnormalities in unmedicated schizophrenia. Psychiatry Res. 95 3 (2000) 237-243
50. Sanders R.D., Schuepbach D., Goldstein G., Haas G.L., Sweeney J.A., and Keshavan M.S. Relationships between cognitive and neurological performance in neuroleptic-naive psychosis. J. Neuropsychiatry Clin. Neurosci. 16 4 (2004) 480-487
51. Scheffer R.E. Abnormal neurological signs at the onset of psychosis. Schizophr. Res. 70 1 (2004) 19-26
52. Schroder J., Niethammer R., Geider F.J., Reitz C., Binkert M., Jauss M., and Sauer H. Neurological soft signs in schizophrenia. Schizophr. Res. 6 1 (1991) 25-30
53. Schroder J., Silvestri S., Bubeck B., Karr M., Demisch S., Scherrer S., Geider F.J., and Sauer H. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol. Psychiatry 43 9 (1998) 660-665
54. Seidman L.J., Kremen W.S., Koren D., Faraone S.V., Goldstein J.M., and Tsuang M.T. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr. Res. 53 1-2 (2002) 31-44
55. Smith A.G., Neill J.C., and Costall B. The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset. Pharmacol. Biochem. Behav. 63 2 (1999) 201-211
56. Tarpey T., and Sanders R.D. Linear conditional expectation for discretized distributions. J. Appl. Stat. 31 (2004) 361-372
57. Torrey E.F., Bowler A.E., Taylor E.H., and Gottesman I.I. Schizophrenia and Manic-Depressive Disorder: the Biological Roots of Mental Illness as Revealed by the Landmark Study of Identical Twins (1994), Basic Books, New York 127-138
58. Whitty P., Clarke M., Browne S., McTigue O., Kamali M., Feeney L., Lane A., Kinsella A., Waddington J.L., Larkin C., and O'Callaghan E. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol. Med. 33 8 (2003) 1479-1484
59. Williams J.T., and Blangero J. Power of variance component linkage analysis-II. Discrete traits. Ann. Hum. Genet. 68 Pt 6 (2004) 620-632
60. Wong A.H., Voruganti L.N., Heslegrave R.J., and Awad A.G. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr. Res. 23 2 (1997) 139-146
61. Yazici A.H., Demir B., Yazici K.M., and Gogus Arn. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr. Res. 58 2-3 (2002) 241-246